{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:42:10Z","timestamp":1790638930869,"version":"4.1.0"},"posted":{"date-parts":[[2026,6,9]]},"group-title":"Immunology","reference-count":82,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Cutaneous leishmaniasis is a parasitic skin disease for which current treatments often fail, highlighting the need for new therapeutic approaches. While high parasite burdens are associated with delayed healing, excessive protective immune responses, including elevated IFN-\u03b3 production, have also been linked to worse clinical outcomes, indicating that immunopathology contributes significantly to disease progression. Acriflavine is an antimicrobial compound with reported anti-leishmanial activity and the ability to inhibit hypoxia-driven responses. Because\n                  <jats:italic>Leishmania<\/jats:italic>\n                  -infected skin is hypoxic in both mice and humans, and hypoxia has been implicated in disease pathogenesis, we investigated whether acriflavine alters the course of cutaneous leishmaniasis by affecting parasite control and\/or host immune responses. We found that acriflavine treatment significantly reduced lesion size in\n                  <jats:italic>Leishmania major<\/jats:italic>\n                  -infected mice. Unexpectedly, this improvement occurred without changes in parasite burden. Instead, acriflavine treatment reduced the frequency of dendritic cells within lesions and decreased their expression of MHC class II, which correlated with fewer IFN-\u03b3-producing CD4 T cells at the site of infection. These findings indicate that acriflavine ameliorates disease by limiting dendritic cell activation and subsequent IFN-\u03b3-driven immunopathology rather than enhancing parasite clearance. Together, our results identify acriflavine as a potential host-directed therapeutic strategy for cutaneous leishmaniasis and support targeting hypoxia-associated pathways to reduce tissue damage driven by excessive inflammatory responses.\n                <\/jats:p>","DOI":"10.64898\/2026.06.05.730355","type":"posted-content","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T21:45:14Z","timestamp":1781041514000},"source":"Crossref","is-referenced-by-count":1,"title":["Acriflavine attenuates inflammatory pathology in cutaneous leishmaniasis independently of parasite control"],"prefix":"10.64898","author":[{"given":"Erin A.","family":"Fowler","sequence":"first","affiliation":[{"name":"Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University; Columbus, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9491-0384","authenticated-orcid":false,"given":"Fernanda O.","family":"Novais","sequence":"additional","affiliation":[{"name":"Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University; Columbus, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026061114053615000_2026.06.05.730355v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.72"},{"key":"2026061114053615000_2026.06.05.730355v1.2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.62.3.837-842.1994"},{"key":"2026061114053615000_2026.06.05.730355v1.3","doi-asserted-by":"publisher","DOI":"10.1086\/315071"},{"key":"2026061114053615000_2026.06.05.730355v1.4","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.12.6734-6740.2002"},{"key":"2026061114053615000_2026.06.05.730355v1.5","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.12.7853-7859.2005"},{"key":"2026061114053615000_2026.06.05.730355v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2005.06.004"},{"key":"2026061114053615000_2026.06.05.730355v1.7","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762007005000069"},{"key":"2026061114053615000_2026.06.05.730355v1.8","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.20449"},{"key":"2026061114053615000_2026.06.05.730355v1.9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2172-14-52","article-title":"Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropica","volume":"14","year":"2013","journal-title":"BMC Immunol"},{"key":"2026061114053615000_2026.06.05.730355v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.12.016"},{"key":"2026061114053615000_2026.06.05.730355v1.11","doi-asserted-by":"crossref","first-page":"e0005116","DOI":"10.1371\/journal.pntd.0005116","article-title":"Gene Expression Profile of High IFN-\u03b3 Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous Leishmaniasis","volume":"10","year":"2016","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"2026061114053615000_2026.06.05.730355v1.12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax4204"},{"key":"2026061114053615000_2026.06.05.730355v1.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.2009.01125.x"},{"key":"2026061114053615000_2026.06.05.730355v1.14","doi-asserted-by":"crossref","first-page":"660183","DOI":"10.3389\/fimmu.2021.660183","article-title":"Host-Directed Therapies for Cutaneous Leishmaniasis","volume":"12","year":"2021","journal-title":"Front Immunol"},{"key":"2026061114053615000_2026.06.05.730355v1.15","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.37.3.660"},{"key":"2026061114053615000_2026.06.05.730355v1.16","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.53.2.312"},{"key":"2026061114053615000_2026.06.05.730355v1.17","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182013001029"},{"key":"2026061114053615000_2026.06.05.730355v1.18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00436-012-3163-8","article-title":"Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp","volume":"112","year":"2013","journal-title":"Parasitol Res"},{"key":"2026061114053615000_2026.06.05.730355v1.19","doi-asserted-by":"publisher","DOI":"10.1021\/cb500476q"},{"key":"2026061114053615000_2026.06.05.730355v1.20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/0972-9062.213451","article-title":"Combination and monotherapy of leishmania major infection in balb\/c mice using plant extracts and herbicides","volume":"49","year":"2012","journal-title":"J Vector Borne Dis"},{"key":"2026061114053615000_2026.06.05.730355v1.21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00573"},{"key":"2026061114053615000_2026.06.05.730355v1.22","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-012-8349-8"},{"key":"2026061114053615000_2026.06.05.730355v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0227-y"},{"key":"2026061114053615000_2026.06.05.730355v1.24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","article-title":"Hypoxia signaling in human health and diseases: implications and prospects for therapeutics","volume":"7","year":"2022","journal-title":"Sig Transduct Target Ther"},{"key":"2026061114053615000_2026.06.05.730355v1.25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41577-024-01087-5","article-title":"How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia","volume":"25","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"2026061114053615000_2026.06.05.730355v1.26","doi-asserted-by":"crossref","first-page":"703084","DOI":"10.3389\/fcell.2021.703084","article-title":"Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease","volume":"9","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026061114053615000_2026.06.05.730355v1.27","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.24.9361-9374.2003"},{"key":"2026061114053615000_2026.06.05.730355v1.28","doi-asserted-by":"crossref","first-page":"14978","DOI":"10.1038\/s41598-017-14990-w","article-title":"HIF-1\u03b1-Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"2026061114053615000_2026.06.05.730355v1.29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-745588"},{"key":"2026061114053615000_2026.06.05.730355v1.30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/cancers13010102","article-title":"Acriflavine, a Potent Inhibitor of HIF-1\u03b1, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-Hypoxic Conditions","volume":"13","year":"2020","journal-title":"Cancers"},{"key":"2026061114053615000_2026.06.05.730355v1.31","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.3390\/cancers13194801","article-title":"Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2\u03b1 Inhibitor-Resistant Clear Cell Renal Cell Carcinoma","volume":"13","year":"2021","journal-title":"Cancers"},{"key":"2026061114053615000_2026.06.05.730355v1.32","doi-asserted-by":"crossref","first-page":"1271118","DOI":"10.3389\/fimmu.2023.1271118","article-title":"Acriflavine, a HIF-1 inhibitor, preserves vision in an experimental autoimmune encephalomyelitis model of optic neuritis","volume":"14","year":"2023","journal-title":"Front Immunol"},{"key":"2026061114053615000_2026.06.05.730355v1.33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12951-025-03395-x","article-title":"Photo-controlled co-delivery of verteporfin and acriflavine via platelets achieves potentiated glioblastoma-targeted photodynamic therapy","volume":"23","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"2026061114053615000_2026.06.05.730355v1.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-011-0855-y"},{"key":"2026061114053615000_2026.06.05.730355v1.35","doi-asserted-by":"crossref","unstructured":"Sallais J , Park C , Alahari S , Porter T , Liu R , Kurt M , Farrell A , Post M , Caniggia I. HIF1 inhibitor acriflavine rescues early-onset preeclampsia phenotype in mice lacking placental prolyl hydroxylase domain protein 2. JCI Insight 7:e158908.","DOI":"10.1172\/jci.insight.158908"},{"key":"2026061114053615000_2026.06.05.730355v1.36","first-page":"e00504","article-title":"Oxygen and immunity to Leishmania infection","volume":"93","year":"2025","journal-title":"Infection and Immunity"},{"key":"2026061114053615000_2026.06.05.730355v1.37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011576"},{"key":"2026061114053615000_2026.06.05.730355v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2012.01.007"},{"key":"2026061114053615000_2026.06.05.730355v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.121"},{"key":"2026061114053615000_2026.06.05.730355v1.40","doi-asserted-by":"crossref","unstructured":"Fowler EA , Amorim CF , Mostacada K , Yan A , Sacramento LA , Stanco RA , Hales EDS , Varkey A , Zong W , Wu GD , de Oliveira CI , Collins PL , Novais FO. 2024. Neutrophil-mediated hypoxia drives pathogenic CD8+ T cell responses in cutaneous leishmaniasis. J Clin Invest 134.","DOI":"10.1172\/JCI177992"},{"key":"2026061114053615000_2026.06.05.730355v1.41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601080"},{"key":"2026061114053615000_2026.06.05.730355v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2004.09.002"},{"key":"2026061114053615000_2026.06.05.730355v1.43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600717"},{"key":"2026061114053615000_2026.06.05.730355v1.44","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1016\/j.jid.2025.04.029","article-title":"Hypoxia and IL-15 Cooperate to Induce Perforin Expression by CD8 T Cells and Promote Damage to the Skin in Murine Cutaneous Leishmaniasis","volume":"145","year":"2025","journal-title":"Journal of Investigative Dermatology"},{"key":"2026061114053615000_2026.06.05.730355v1.45","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00088-19"},{"key":"2026061114053615000_2026.06.05.730355v1.46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004938"},{"key":"2026061114053615000_2026.06.05.730355v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21891-z"},{"key":"2026061114053615000_2026.06.05.730355v1.48","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/pathogens10121584","article-title":"HIF-\u03b1 Activation Impacts Macrophage Function during Murine Leishmania major Infection","volume":"10","year":"2021","journal-title":"Pathogens"},{"key":"2026061114053615000_2026.06.05.730355v1.49","doi-asserted-by":"crossref","unstructured":"Bowlin A , Roys H , Wanjala H , Bettadapura M , Venugopal G , Surma J , Simon MC , Weinkopff T . 2021. Hypoxia-Inducible Factor Signaling in Macrophages Promotes Lymphangiogenesis in Leishmania major Infection. Infection and Immunity 89.","DOI":"10.1128\/IAI.00124-21"},{"key":"2026061114053615000_2026.06.05.730355v1.50","doi-asserted-by":"crossref","unstructured":"Fry LG , Washam CL , Roys H , Bowlin AK , Venugopal G , Bird JT , Byrum SD , Weinkopff T . 2025. HIF-\u03b1 signaling regulates the macrophage inflammatory response during Leishmania major infection. Front Immunol 16.","DOI":"10.3389\/fimmu.2025.1487311"},{"key":"2026061114053615000_2026.06.05.730355v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/nature01152"},{"key":"2026061114053615000_2026.06.05.730355v1.52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.11.7147"},{"key":"2026061114053615000_2026.06.05.730355v1.53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003243"},{"key":"2026061114053615000_2026.06.05.730355v1.54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400728"},{"key":"2026061114053615000_2026.06.05.730355v1.55","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230558"},{"key":"2026061114053615000_2026.06.05.730355v1.56","doi-asserted-by":"crossref","first-page":"8449","DOI":"10.1038\/s41467-023-44297-6","article-title":"Antigen recognition reinforces regulatory T cell mediated Leishmania major persistence","volume":"14","year":"2023","journal-title":"Nat Commun"},{"key":"2026061114053615000_2026.06.05.730355v1.57","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.108"},{"key":"2026061114053615000_2026.06.05.730355v1.58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56336-8"},{"key":"2026061114053615000_2026.06.05.730355v1.59","doi-asserted-by":"crossref","unstructured":"de Freitas e Silva R , G\u00e1lvez RI , Pereira VRA , de Brito MEF , Choy SL , Lotter H , Bosurgi L , Jacobs T. 2020. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4+ T Effector and Regulatory T Cells in Cutaneous Leishmaniasis. Front Immunol 11.","DOI":"10.3389\/fimmu.2020.574491"},{"key":"2026061114053615000_2026.06.05.730355v1.60","doi-asserted-by":"crossref","unstructured":"Garcia de Moura R , Covre LP , Fantecelle CH , Gajardo VAT , Cunha CB , Stringari LL , Belew AT , Daniel CB , Zeidler SVV , Tadokoro CE , de Matos Guedes HL , Zanotti RL , Mosser D , Falqueto A , Akbar AN , Gomes DCO. 2021. PD-1 Blockade Modulates Functional Activities of Exhausted-Like T Cell in Patients With Cutaneous Leishmaniasis. Front Immunol 12.","DOI":"10.3389\/fimmu.2021.632667"},{"key":"2026061114053615000_2026.06.05.730355v1.61","doi-asserted-by":"crossref","first-page":"37856","DOI":"10.1038\/s41598-025-21669-0","article-title":"Leishmania amazonensis infection induces PD-L1 expression on dendritic cells and impairs Th1 responses in vitro and in vivo","volume":"15","year":"2025","journal-title":"Sci Rep"},{"key":"2026061114053615000_2026.06.05.730355v1.62","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.004184-0"},{"key":"2026061114053615000_2026.06.05.730355v1.63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2009.00151.x"},{"key":"2026061114053615000_2026.06.05.730355v1.64","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.chembiol.2021.11.006","article-title":"Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses","volume":"29","year":"2022","journal-title":"Cell Chemical Biology"},{"key":"2026061114053615000_2026.06.05.730355v1.65","doi-asserted-by":"publisher","DOI":"10.18632\/ONCOTARGET.11825"},{"key":"2026061114053615000_2026.06.05.730355v1.66","doi-asserted-by":"publisher","DOI":"10.1038\/nri2550"},{"key":"2026061114053615000_2026.06.05.730355v1.67","doi-asserted-by":"crossref","unstructured":"Arellano G , Ottum PA , Reyes LI , Burgos PI , Naves R . 2015. Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Front Immunol 6.","DOI":"10.3389\/fimmu.2015.00492"},{"key":"2026061114053615000_2026.06.05.730355v1.68","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1177\/1352458518791683","article-title":"Multiple sclerosis disease progression: Contributions from a hypoxia\u2013inflammation cycle","volume":"25","year":"2019","journal-title":"Mult Scler"},{"key":"2026061114053615000_2026.06.05.730355v1.69","first-page":"6","article-title":"A Hypoxia-Inflammation Cycle and Multiple Sclerosis: Mechanisms and Therapeutic Implications","volume":"27","year":"2024","journal-title":"Curr Treat Options Neurol"},{"key":"2026061114053615000_2026.06.05.730355v1.70","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa427"},{"key":"2026061114053615000_2026.06.05.730355v1.71","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1042\/CS20170981","article-title":"Understanding a role for hypoxia in lesion formation and location in the deep and periventricular white matter in small vessel disease and multiple sclerosis","volume":"131","year":"2017","journal-title":"Clin Sci (Lond"},{"key":"2026061114053615000_2026.06.05.730355v1.72","doi-asserted-by":"crossref","unstructured":"Lovett-Racke AE , Racke MK . 2018. Role of IL-12\/IL-23 in the Pathogenesis of Multiple Sclerosis, p. 115\u2013139. In Neuroinflammation. Elsevier.","DOI":"10.1016\/B978-0-12-811709-5.00005-3"},{"key":"2026061114053615000_2026.06.05.730355v1.73","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1620"},{"key":"2026061114053615000_2026.06.05.730355v1.74","doi-asserted-by":"crossref","unstructured":"Gong X , Yang S-Y , Wang Z-Y , Tang M . 2024. The role of hypoxic microenvironment in autoimmune diseases. Front Immunol 15.","DOI":"10.3389\/fimmu.2024.1435306"},{"key":"2026061114053615000_2026.06.05.730355v1.75","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01898-7"},{"key":"2026061114053615000_2026.06.05.730355v1.76","doi-asserted-by":"publisher","DOI":"10.3390\/cells12020314"},{"key":"2026061114053615000_2026.06.05.730355v1.77","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00816-x"},{"key":"2026061114053615000_2026.06.05.730355v1.78","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cyto.2006.07.016","article-title":"Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients","volume":"35","year":"2006","journal-title":"Cytokine"},{"key":"2026061114053615000_2026.06.05.730355v1.79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2334-7-33","article-title":"IFNG +874T\/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmaniainduced IFN-\u03b3 production","volume":"7","year":"2007","journal-title":"BMC Infect Dis"},{"key":"2026061114053615000_2026.06.05.730355v1.80","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/cid\/ciz810","article-title":"A Single Haplotype of IFNG Correlating With Low Circulating Levels of Interferon-\u03b3 Is Associated With Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis","volume":"71","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026061114053615000_2026.06.05.730355v1.81","doi-asserted-by":"publisher","DOI":"10.1006\/expr.2001.4656"},{"key":"2026061114053615000_2026.06.05.730355v1.82","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040172"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.05.730355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:05:47Z","timestamp":1781211947000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.06.05.730355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":82,"URL":"https:\/\/doi.org\/10.64898\/2026.06.05.730355","relation":{},"subject":[],"published":{"date-parts":[[2026,6,9]]},"subtype":"preprint"}}